Sida 1 från 57 resultat
BACKGROUND
To evaluate the effectiveness of the levonorgestrel intrauterine system (LNG-IUS) in obese women with heavy menstrual bleeding in Counties Manukau Auckland area, New Zealand.
METHODS
Prospective observational study in a tertiary teaching hospital. Twenty women with heavy menstrual
OBJECTIVE
To compare the efficacy and safety of endometrial ablation (EA) among obese versus non-obese women.
METHODS
A retrospective cohort study of 666 women who underwent EA at the Mayo Clinic, Rochester, USA, between January 1, 1998, and December 31, 2005, was conducted. Obesity was defined as a
OBJECTIVE
To evaluate quality of life (QoL) after radiofrequency endometrial ablation (RFEA) for heavy menstrual bleeding among women at high surgical risk.
METHODS
An observational study was undertaken among women aged at least 18 years who underwent RFEA at Hanover Medical School, Germany, between
OBJECTIVE
To assess the proportion of iron deficiency that is not detected with a screening hemoglobin or complete blood count (CBC) alone in young women with heavy menstrual bleeding.
METHODS
Retrospective review of electronic medical records.
METHODS
Nationwide Children's Hospital in Columbus,
The implications of obesity in childhood and adolescence resonate into adulthood and have implications at different levels that include psychosocial and health issues that impact beyond reproductive performance. This chapter explores the various facets and consequences on gynaecological issues of
BACKGROUND
A 10-year-old, female bonnet monkey (Macaca radiata) showed abnormal menstrual cycle length with heavy menstrual bleeding for 6-8 days.
METHODS
Uterine ultrasound and histological examinations of endometrium by endometrial biopsy.
RESULTS
An ultrasound examination of the uterine cavity
Twenty-two consecutive patients weighing 100 kg or more and requiring hysterectomy were treated by laparoscopic assisted vaginal hysterectomy. The mean patient weight was 105.2 kg. In 21 patients, the indication for hysterectomy was menorrhagia (9 of these had uterine fibroids) and one patient had
BACKGROUND
Gonadotropin-releasing hormone agonists (GnRH-a) are effective in reducing the pituitary release of gonadotropins, which, in turn, decrease ovarian steroidogenesis. The resulting menopausal state decreases the volume and vascular supply to uterine leiomyomas. Peripheral adipose tissue
OBJECTIVE
To evaluate the safety and efficacy of thermal balloon therapy in a subset of women with menorrhagia considered to be high-risk surgical candidates for hysteroscopic endometrial ablation or hysterectomy.
METHODS
Prospective, observational study (Canadian Task Force classification
The levonorgestrel intrauterine device (LNG-IUD) is a safe, effective, long-acting, reversible contraceptive that reduces unintended pregnancy and decreases heavy menstrual bleeding. Many procedures such as IUD insertion are more challenging in overweight and obese women. The objective of this study
Adolescence in girls is marked by a host of physical and psychological changes including those associated with menstruation. Heavy menstrual bleeding is one of the most commonly encountered medical problems during transition from childhood to adulthood. Although common, it is likely underreported
Menorrhagia--menstrual periods lasting longer than 7 days and totaling blood losses greater than 80mL--affects 9%-14% of otherwise healthy women, and it can signal cancer, an endocrinologic disorder, or gynecologic disease. Blood loss can be high enough to result in anemia, fatigue, and syncope.
OBJECTIVE
To describe the success rate of and the quality of life after global endometrial ablation in an obese population.
METHODS
A follow-up survey was mailed to 72 women who had undergone global endometrial ablation. The survey included a menorrhagia-specific NovaSure endometrial ablation
OBJECTIVE
To compare changes in anthropometric measures [body mass index (BMI), body weight] of obese patients treated with diet and exercise alone or additionally sibutramine, orlistat or the combination of both drugs, respectively. To describe encountered adverse effects.
METHODS
Short-term (12
The case is reported of a 32-year-old morbidly obese white woman who used adalimumab 40 mg every other week for 4 months for psoriatic arthritis, psoriasis vulgaris and inverse psoriasis with total clearance of her psoriasis who developed menorrhagia (at least twice the number of pads used daily for